WNT4在脑胶质瘤中甲基化下调及抑制恶性胶质瘤细胞增殖的研究

doi:10.11904/j.issn.1002-3070.2020.02.013

摘要/Abstract

摘要： 目的探讨WNT4在脑胶质瘤细胞系和组织中细胞系的表达与甲基化对脑胶质瘤细胞系U87增殖的作用和机制。方法 qRT-PCR和免疫蛋白印迹实验分析WNT4在脑胶质瘤组织中的表达和甲基化及WNT4在脑胶质瘤细胞系中的表达;以胶质瘤U87细胞为本实验研究对象,分别转染慢病毒载体pLVX-Gfp-WNT4(实验组)和pLVX-Gfp-NC(对照组);细胞增殖和克隆形成实验分析WNT4基因对细胞增殖的影响;免疫蛋白印迹法验证WNT4对Wnt/β-catenin信号通路的影响。结果与正常人星形胶质细胞相比,WNT4 mRNA在脑胶质瘤细胞系中的表达下调(P＜0.001),与正常脑组织相比,WNT4 mRNA和蛋白在脑胶质瘤组织中表达下调(P＜0.001);脑胶质瘤分级越高WNT4 mRNA表达越低(P＜0.001),高表达WNT4 mRNA患者的预后好(P＜0.001);WNT4在脑胶质瘤中甲基化程度明显高于正常脑组织。过表达WNT4后细胞活性和增殖能力受到抑制(P＜0.001);恢复WNT4表达后Wnt/β-catenin信号通路及其下游细胞因子明显受到抑制。结论 WNT4在人脑胶质瘤组织中表达甲基化下调,通过抑制Wnt/β-catenin信号通路参与脑胶质瘤的进展。

关键词: 脑胶质瘤, WNT4, 甲基化, 细胞增殖, Wnt/β-catenin

Abstract: Objective The aims of this study were to investigate the expression and methylation of WNT4 in glioma tissues and malignant glioma cell lines,and its effect and mechanism on the proliferation of glioma U87 cell line.Methods qRT-PCR and Western blot were used to analyze the expression and methylation of WNT4 in human glioma tissues and the expression of WNT4 in U87 cells.MSP was used to analysis the methylation of Wnt4 in glioma tissues.U87 cells were used as experimental cells transfected with lentiviral vectors pLVX-Gfp-WNT4(experimental group)and pLVX-Gfp-NC(control group).Cell proliferation and clone formation experiments were performed to analyze the effect of WNT4A gene on cell proliferation.Western blot was used to verify the effect of WNT4 on the WNT/β-catenin signal pathway.Results Compared with normal human astrocytes,WNT4 mRNA and protein were significantly down-regulated in glioma tissues and cells(P＜0.001).WNT4 methylation was significantly increased in gliomas tissues.The expression of WNT4 was related to the grade of glioma,and the good prognosis of patients with the high expression of WNT4 mRNA;the degree of methylation of WNT4 in glioma tissues was significantly higher than that of normal brain tissues.The Re-expression of WNT4 in significantly decreased in cell viability and proliferation of U87 cells(P＜0.001);The WNT/β-catenin signaling pathway and its downstream cytokines were significantly suppressed after WNT4 expression was restored in U87 cells.Conclusion The expression of WNT4 is down-regulated in human glioma tissues and participates in the progression of gliomas by inhibiting the Wnt/β-catenin signaling pathway.

Key words: Malignant glioma, WNT4,Methylation, Cell proliferation, Wnt/β-catenin

中图分类号:

R793.4

张巍, 姜晓东, 迟大鹏. WNT4在脑胶质瘤中甲基化下调及抑制恶性胶质瘤细胞增殖的研究[J]. 实用肿瘤学杂志, 2020, 34(2): 156-162.

ZHANG Wei, JIANG Xiaodong, CHI Dapeng. WNT4 down-regulates methylation of glioma and inhibits malignant glioma cell proliferation[J]. Journal of Practical Oncology, 2020, 34(2): 156-162.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.02.013

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I2/156

参考文献

1 Chen A,Zhong L,Lv J.FOXL1 overexpression is associated with poor outcome in patients with glioma[J].Oncol Lett,2019,18(1):751-757.
2 Yan Z,Yang J,Fan L,et al.31 gene expression-based signatures serve as indicators of prognosis for patients with glioma[J].Oncol Lett,2019,18(1):291-297.
3 Zhang S,Gao M,Yu L.GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription[J].Cancer Med,2019,8(11):5242-5253.
4 Sun C,Liu X,Wang B,et al.Endocytosis-mediated mitochondrial transplantation:transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity[J].Theranostics,2019,9(12):3595-3607.
5 Lang CMR,Chan CK,Veltri A,et al.Wnt signaling pathways in keratinocyte carcinomas[J].Cancers(Basel),2019,11(9):1216.
6 Katoh M.Multi-layered prevention and treatment of chronic inflammation,organ fibrosis and cancer associated with canonical Wnt/β-catenin signaling activation(Review)[J].Int J Mol Med,2018,42(2):713-725.
7 Alamoud KA,Kukuruzinska MA.Emerging insights into Wnt/β-catenin signaling in head and neck cancer[J].J Dent Res,2018,97(6):665-673.
8 Baron R,Gori F.Targeting WNT signaling in the treatment of osteoporosis[J].Curr Opin Pharmacol,2018,40(5):134-141.
9 Fan L,Tan B,Li Y,et al.Silencing of ZNF139-siRNA induces apoptosis in human gastric cancer cell line BGC823[J].Int J Clin Exp Pathol,2015,8(10):12428-12436.
10 Hao YJ,Li Y,Fan LQ,et al.Role of RNA-interference-induced zinc finger protein 139 suppression in gastric cancer cell sensitivity to chemotherapeutic agents[J].Oncol Lett,2015,10(3):1333-1338.
11 Que Y,Fang Z,Guan Y,et al.LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival[J].Cancer Biol Med,2019,16(2):331-340.
12 Wang YY,Chen YK,Hu CS,et al.MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death[J].Oral Dis,2019,25(3):758-771.
13 van Andel H,Kocemba KA,Spaargaren M,et al.Aberrant Wnt signaling in multiple myeloma:molecular mechanisms and targeting options[J].Leukemia,2019,33(5):1063-1075.
14 Yu J,Xie Y,Li M,et al.Association between SFRP promoter hypermethylation and different types of cancer:a systematic review and meta-analysis[J].Oncol Lett,2019,18(4):3481-3492.
15 Wu J,Li H,Shi M,et al.TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells[J].J Exp Clin Cancer Res,2019,38(1):348-357.
16 Zhang C,Zhang M,Ge S,et al.Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer[J].Cancer Med,2019,8(10):4766-4781.
17 Xin Y,Dong K,Cao F,et al.Studies of hTERT DNA methylation assays on the human age prediction[J].Int J Legal Med,2019,133(5):1333-1339.
18 Ibrahim J,Op de Beeck K,Fransen E,et al.Methylation analysis of gasdermine shows great promise as a biomarker for colorectal cancer[J].Cancer Med,2019,8(5):2133-2145.
19 Veeck J,Niederacher D,An H,et al.Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis[J].Oncogene,2006,25(24):3479-3488.
20 Veeck J,Noetzel E,Bektas N,et al.Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer[J].Mol Cancer,2008,7(2):83-89.
21 Chim CS,Chan WW,Pang A,et al.Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia:an independent poor prognostic factor[J].Leukemia,2006,20(5):907-909.
22 Zhang L,Wang D,Han X,et al.Mechanism of methylation and acetylation of high GDNF transcription in glioma cells:a review[J].Heliyon,2019,5(6):e01951.
23 Lv M,Wang Y,Wu W,et al.C-Myc inhibitor 10058?F4 increases the efficacy of dexamethasone on acute lymphoblastic leukaemia cells[J].Mol Med Rep,2018,18(1):421-428.

[1]	王飞, 朱贲贲. 丙泊酚经HIF-1α信号通路对头颈鳞状细胞癌SCC-74细胞增殖、凋亡与侵袭的影响[J]. 实用肿瘤学杂志, 2020, 34(2): 120-125.
[2]	赵楠楠, 秦文, 韩永焕, 鲁静, 李亚敏, 徐亚君. SOX11 抑制食管癌细胞增殖和迁移的机制研究[J]. 实用肿瘤学杂志, 2020, 34(1): 17-23.
[3]	包乐, 唐丽萍. EphB6受体在恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 83-87.
[4]	黄梨, 龙佑梅, 付义霞, 夏良斌. 紫檀芪对卵巢癌SKOV3细胞凋亡和糖酵解的影响及机制研究[J]. 实用肿瘤学杂志, 2019, 33(6): 502-507.
[5]	张谊微, 石晶, 刘宇鹏, 曹丽明, 胡付兰, 赵亚双. 外周血USP1基因甲基化与大肠癌预后风险的关系[J]. 实用肿瘤学杂志, 2019, 33(5): 420-424.
[6]	申利, 魏军成. miRNA-409-3p表达水平对宫颈癌细胞增殖及顺铂化疗敏感性的影响[J]. 实用肿瘤学杂志, 2019, 33(4): 300-304.
[7]	闫若东, 任山, 隋文印, 朴仁京. TMEM45A在肾透明细胞癌中的表达及作用机制研究[J]. 实用肿瘤学杂志, 2019, 33(4): 317-322.
[8]	普睿, 朱琳, 夏婷婷, 毕皓然, 孙鸿儒, 黄浩, 张磊, 赵亚双. 外周血STAT1,STAT3基因启动子CpG岛甲基化状态与大肠癌预后关系的研究[J]. 实用肿瘤学杂志, 2019, 33(4): 346-351.
[9]	张玫茵娄阁. N6-甲基腺嘌呤与癌症的研究进展[J]. 实用肿瘤学杂志, 2019, 33(4): 357-360.
[10]	秦文,赵楠楠,韩永焕,徐亚君. ZNF436在胃癌中的表达及调控WNT/β-catenin对胃癌细胞迁移及侵袭的影响[J]. 实用肿瘤学杂志, 2019, 33(3): 222-227.
[11]	李烁,张楠楠,李亮亮,龙志平,尹慧慧,赵亚双,王帆. 外周血白细胞PDE4C基因甲基化及环境因素交互作用与乳腺癌发病的关系[J]. 实用肿瘤学杂志, 2019, 33(3): 233-238.
[12]	白晓斌, 霍龙伟, 谢万福, 徐高峰, 王茂德. Chk1在胶质母细胞瘤中的表达及其与肿瘤生物学行为和预后生存的关联性[J]. 实用肿瘤学杂志, 2019, 33(2): 122-127.
[13]	白玉贤, 马仲娟, 苏颖玲, 慕安国, 谢蕊. 胃癌患者FHIT、hMLH1、p16、RAR-beta、Reprimo和TIMP3基因的甲基化研究[J]. 实用肿瘤学杂志, 2019, 33(1): 8-13.
[14]	袁桂霞, 李岩, 冯婉琪, 夏小娟, 李旭. 抑癌基因DKK2抑制儿童肾母细胞瘤细胞增殖的机制研究[J]. 实用肿瘤学杂志, 2019, 33(1): 14-20.
[15]	卞秀森, 李光, 关欣宇, 张伊, 狄畅, 马璨. UHRF1通过调控细胞自噬抑制肺腺癌细胞增殖的分子机制研究[J]. 实用肿瘤学杂志, 2018, 32(6): 498-502.